Wilmington, Delaware, United States, March 25, 2017 -- The report “Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)), Indication (Asthma and COPD), End User (Patients and R and D) - Global Opportunity Analysis and Industry Forecast 2022”, available on MarketIntelReports, estimates that the market will register a whopping 63.3% CAGR during the forecast period.
Browse numerous Market Tables as well as Figures which are spread through 202 Pages and an in-depth TOC on the “Smart Inhalers Market Forecast 2022” http://www.marketintelreports.com/report/LI%20161715/smart-inhalers-market-by-product-inhalers-and-nebulizers-dry-powder-inhalers-dpis-metered-dose-inhalers-mdis-indication-asthma-and-copd-end-user-patients-and-r-and-d--global-opportunity-analysis-and-industry-forecast-2014--2022
Scope & Regional Forecast of the Smart Inhalers Market
Smart inhalers are clip-on sensors, also known as connected inhalers, which are attached to the traditional inhalers. They are used to track the medication, dosage, and time taken for each dose. Linked wirelessly to the cloud, smart inhalers are a part of “Internet of Things,” thus providing correct use of the medication, improved adherence to the inhaler, and better health outcomes. Doctors and patients can easily benefit from the use of smart inhalers as they monitor the dosage and provide reminders at the time of the dose, which can be recorded for understanding the patient’s daily routine.
Request Sample PDF Brochure @ http://www.marketintelreports.com/pdfdownload.php?id=li%20161715
The world smart inhalers market is analyzed under three different scenarios, namely, moderate growth, rapid growth, and diminishing growth. Under the moderate growth scenario, smart inhalers market is estimated to reach $191 million by 2022, growing at a CAGR of 63.3% during 2016 to 2022. Market growth is attributed to the rapid increase in the incidence of respiratory diseases, rise in air pollution, and growth in healthcare burden, due to higher cases of asthma and COPD. In addition, expected increase in adherence to smart inhalers is another major factor for the growth of smart inhalers market. However, limited availability of smart inhalers, high cost of asthma and COPD treatment, and resistance towards adoption of smart inhalers are expected to hinder the market growth.
North America was the leading revenue-generating region, whereas Asia-Pacific is projected to grow at the highest CAGR of 65.3%, owing to rise in demand for smart inhalers and increase in COPD and asthma cases. Companies have adopted product approval and clinical trials as their key development strategies. Increase in focus on clinical trials is mainly for the development of innovative technologies in the field of smart inhalers. In March 2016, Adherium received a product approval to sell its “SmartTurbo” and “SmartTouch” devices in Canada, thereby expanding its product portfolio.
Inquiry before buying report @ http://www.marketintelreports.com/inquiry-before-buying.php?id=li%20161715
Prominent Segmentations Involved in the Smart Inhalers Market
The Smart Inhalers Market can be broken down into various segmentations on the basis of -
- Product: Inhalers and Nebulizers.
- Indication: Asthma and COPD.
- End User: Patients and R&D.
- Geographical Location: North America, Europe, Asia-Pacific and LAMEA.
Some of the sample companies profiled in the Smart Inhalers Market report are as follows:
- Adherium Limited
- Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)
- Propeller Health
- Cohero Health, LLC
- OPKO Health, Inc. (Inspiro Medical Ltd.)
- GlaxoSmithKline plc
- Novartis AG
- AstraZeneca plc
- Boehringer Ingelheim GmbH
- Vectura Group plc
Why buy this report?
- Get a detailed picture of the Smart Inhalers Market.
- Pinpoint growth sectors and identify factors driving change.
- Understand the competitive environment, the market’s major players and leading brands.
- A five-year forecast method is used in order to assess how the market is predicted to develop.
Purchase Smart Inhalers Market Report @ http://www.marketintelreports.com/purchase.php?id=li%20161715
About Us:
MarketIntelReports (MIR) aims to empower our clients to successfully manage and outperform in their business decisions. We do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.
MarketIntelReports currently has more than 150,000 plus titles and 100+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Media Contact:
Company Name: Market Intel Reports
Contact Person: Mayur S
Email: [email protected]
Phone: 1-302-261-5343
Address: 2712 Centerville Road, Suite 400
City: Wilmington
State: Delaware
Country: United States


Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 



